Free Trial

Smart for Life (SMFL) Competitors

Smart for Life logo
$0.0002 0.00 (0.00%)
As of 05/20/2025 02:56 PM Eastern

SMFL vs. AMPE, CALA, CMRA, CLVR, EFTR, ONCSQ, PXMD, ATNFW, LBPSW, and AEHAW

Should you be buying Smart for Life stock or one of its competitors? The main competitors of Smart for Life include Ampio Pharmaceuticals (AMPE), Calithera Biosciences (CALA), Comera Life Sciences (CMRA), Clever Leaves (CLVR), eFFECTOR Therapeutics (EFTR), OncoSec Medical (ONCSQ), PaxMedica (PXMD), 180 Life Sciences (ATNFW), 4D pharma (LBPSW), and Aesther Healthcare Acquisition (AEHAW). These companies are all part of the "pharmaceutical products" industry.

Smart for Life vs.

Smart for Life (NASDAQ:SMFL) and Ampio Pharmaceuticals (NYSE:AMPE) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, analyst recommendations, earnings, community ranking, institutional ownership, media sentiment and risk.

In the previous week, Ampio Pharmaceuticals had 1 more articles in the media than Smart for Life. MarketBeat recorded 1 mentions for Ampio Pharmaceuticals and 0 mentions for Smart for Life. Smart for Life's average media sentiment score of 0.00 equaled Ampio Pharmaceuticals'average media sentiment score.

Company Overall Sentiment
Smart for Life Neutral
Ampio Pharmaceuticals Neutral

28.4% of Smart for Life shares are owned by institutional investors. Comparatively, 5.7% of Ampio Pharmaceuticals shares are owned by institutional investors. 31.7% of Smart for Life shares are owned by company insiders. Comparatively, 3.3% of Ampio Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Company Net Margins Return on Equity Return on Assets
Smart for LifeN/A N/A N/A
Ampio Pharmaceuticals N/A N/A N/A

Smart for Life received 1 more outperform votes than Ampio Pharmaceuticals when rated by MarketBeat users. Likewise, 100.00% of users gave Smart for Life an outperform vote while only 0.00% of users gave Ampio Pharmaceuticals an outperform vote.

CompanyUnderperformOutperform
Smart for LifeOutperform Votes
1
100.00%
Underperform Votes
No Votes
Ampio PharmaceuticalsOutperform Votes
No Votes
Underperform Votes
78
100.00%

Smart for Life has a beta of 1.63, meaning that its stock price is 63% more volatile than the S&P 500. Comparatively, Ampio Pharmaceuticals has a beta of 3.9, meaning that its stock price is 290% more volatile than the S&P 500.

Ampio Pharmaceuticals has lower revenue, but higher earnings than Smart for Life.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Smart for Life$11.11M0.00-$22.68MN/AN/A
Ampio PharmaceuticalsN/AN/A-$8.63M-$11.010.00

Summary

Smart for Life beats Ampio Pharmaceuticals on 5 of the 8 factors compared between the two stocks.

Get Smart for Life News Delivered to You Automatically

Sign up to receive the latest news and ratings for SMFL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

SMFL vs. The Competition

MetricSmart for LifeMedicinals & botanicals IndustryMedical SectorNASDAQ Exchange
Market Cap$1,000.00$1.16B$5.43B$8.48B
Dividend YieldN/AN/A5.22%4.11%
P/E RatioN/A10.5526.7920.05
Price / Sales0.008.44394.72116.44
Price / CashN/A10.4038.2534.62
Price / Book0.001.466.864.61
Net Income-$22.68M-$54.34M$3.22B$248.19M
7 Day PerformanceN/A2.72%6.83%2.97%
1 Month PerformanceN/A11.88%13.73%16.58%
1 Year PerformanceN/A-38.30%18.22%8.16%

Smart for Life Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SMFL
Smart for Life
N/A$0.00
flat
N/A-100.0%$1,000.00$11.11M0.00110Gap Up
High Trading Volume
AMPE
Ampio Pharmaceuticals
N/A$0.00
+3.3%
N/A-98.7%$4,000.00N/A0.0020Analyst Forecast
Gap Up
CALA
Calithera Biosciences
N/A$0.00
flat
N/A-97.0%$3,000.00N/A0.0060Analyst Forecast
CMRA
Comera Life Sciences
N/AN/AN/AN/A$3,000.00$1.00M0.002
CLVR
Clever Leaves
N/A$0.00
flat
N/A-100.0%$1,000.00$17.42M0.00560
EFTR
eFFECTOR Therapeutics
N/A$0.00
-66.7%
N/A-100.0%$1,000.00$3.55M0.0010Upcoming Earnings
Gap Down
ONCSQ
OncoSec Medical
N/AN/AN/AN/A$1,000.00N/A0.0040
PXMD
PaxMedica
N/A$0.00
flat
N/A-100.0%$1,000.00N/A0.002
ATNFW
180 Life Sciences
N/A$0.01
-3.7%
N/A+21.5%$0.00N/A0.007Positive News
Gap Down
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.01
+205.4%
N/A-89.5%$0.00N/A0.002

Related Companies and Tools


This page (NASDAQ:SMFL) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners